Cassava Sciences | PTIE - Loan Capital

Stock Price
2.04
Daily Change
0.15 7.94%
Monthly
-6.42%
Yearly
-10.13%
Q1 Forecast
1.93

Cassava Sciences reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Abbott USD 11.6B 1.33B Sep/2025
Amgen USD 52.43B 1.33B Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 134.75B 34.91B Sep/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
Geron USD 119.26M 273K Sep/2025
J&J USD 39.41B 173M Sep/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 24.24B 174M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025